Two scientists made huge bets on 'impossible' cancer treatments. They're finally paying off.

• Infectious disease specialists and Democratic lawmakers are opposing a Trump administration plan to eliminate a clinical research unit at the National Institute of Allergy and Infectious Diseases. • The Infectious Diseases Society of America and the HIV Medicine Association cited an August 28 notice from the National Institutes of Health that provided few details and a five-day comment period.

• Researchers from the University of East Anglia and Oxford BioDynamics identified a common biological link for chronic exhaustion across five different health conditions. • The study found that genes related to these conditions are connected to shared networks involving immune responses, cellular energy production, and hormone signaling.

• The CDC, FDA, and state public health officials investigated a multistate outbreak of Salmonella Enteritidis infections linked to shell eggs. • The investigation involved regulatory officials across several states to identify the source of the bacterial contamination.

• Multiple health and infrastructure crises emerged in reports ending September 4, 2026, including a cyclosporiasis outbreak and a surge in measles cases. • Two children died from measles as infection rates reached a 30-year high.

• Editor-in-Chief Jason Gallagher highlighted a proposed Office of Management and Budget (OMB) rule that would restrict federal grants for international research collaborations. • The rule targets the cross-border networks used by infectious disease practitioners to track new pathogens, resistance mechanisms, and outbreaks.

• Donald Trump has introduced new deals regarding drug pricing as part of his health policy updates. • The latest health reports also cover research on the effects of cannabis edibles on driving and the use of Paxlovid for long Covid.

• The National Institutes of Health ended its ban on funding new research projects in South Africa on September 3, 2026. • Director Jay Bhattacharya issued an internal memo requiring that international projects have a clear scientific rationale and the potential to improve the health of Americans.

• Researchers conducted a retrospective review of all novel FDA drug approvals from 2016 through 2024 to analyze the evidence used for authorization. • The study used FDA public records and the ClinicalTrials.gov database to track the number of completed trials and their funding sources.

• The Medicines and Healthcare products Regulatory Agency (MHRA) has suspended the new use of the drug avacopan after concluding that pivotal trial data is no longer reliable. • One pivotal clinical study underpinning the drug's license authorization was found to have compromised integrity and reliability.

• New migraine prevention guidelines were released on Monday to help physicians navigate treatment options and secure insurance prior authorizations. • The updated framework emphasizes the integration of the newest prevention medications currently available on the market.

• Government, industry, and public health sectors are collaborating to increase the adoption of common standards for clinical research data collection and sharing. • The initiative aims to prevent critical health findings from remaining hidden in fragmented data, ensuring that safety and efficacy results are transparent.